Cargando…
Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study: Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules
BACKGROUND: Our study was designed to improve the accuracy of determining whether pulmonary nodules are benign or malignant. METHODS: We evaluated the clinical and imaging features and serum markers: neuron specific enolase (NSE), carcino-embryonic antigen (CEA), cytokeratin fragment antigen 21–1...
Autores principales: | Li, Xianfeng, Zhang, Qinghua, Jin, Xiayun, Cao, Lihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445450/ https://www.ncbi.nlm.nih.gov/pubmed/28545454 http://dx.doi.org/10.1186/s12957-017-1171-y |
Ejemplares similares
-
Radiomics combined with clinical features in distinguishing non-calcifying tuberculosis granuloma and lung adenocarcinoma in small pulmonary nodules
por: Dong, Qing, et al.
Publicado: (2022) -
Immunocyte count combined with CT features for distinguishing pulmonary tuberculoma from malignancy among non-calcified solitary pulmonary solid nodules
por: Liu, Zihao, et al.
Publicado: (2023) -
Liquid biopsies to distinguish malignant from benign pulmonary nodules
por: Tao, Rui, et al.
Publicado: (2021) -
Quantitative Imaging features Improve Discrimination of Malignancy in Pulmonary nodules
por: Balagurunathan, Yoganand, et al.
Publicado: (2019) -
Comparison of Comprehensive Morphological and Radiomics Features of Subsolid Pulmonary Nodules to Distinguish Minimally Invasive Adenocarcinomas and Invasive Adenocarcinomas in CT Scan
por: Qiu, Lu, et al.
Publicado: (2022)